Arkolith/Insider Trading/IPSC/Form 4

Carr Douglas

SVP Finance & OperationsCentury Therapeutics, Inc. (IPSC) · full profile →Form 4 · filed Mar 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$769
Net Open-Market Flow
-$769
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2025Grant(A)96K—$0411K
Mar 10, 2025Sell(S)1K$0.62$769316K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 11, 2025Grant(A)96K—$096K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-005288) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML